ArticleDermatology and therapy2026

Real-world effectiveness and safety of tralokinumab in moderate-to-severe atopic dermatitis with malignancy, chronic infections, and multimorbidity.

Francisco Javier Melgosa Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.